News and Recent Work


  • HealthBeacon

    ByrneWallace advised HealthBeacon in relation to its recent $12 million Series A financing. This brings total funding into the company to date to $15 million.

  • Nuvo Pharmaceuticals

    ByrneWallace advise Nuvo Pharmaceuticals (Ireland) DAC (Nuvo Ireland) in relation to its acquisition of a number of pharmaceutical assets, as part of the completion by Nuvo Pharmaceuticals Inc. (Nuvo) of the acquisition of Aralez Pharmaceuticals Inc.

  • Staycity

    ByrneWallace advise Staycity on the 5 per cent stake acquired by John Pollard Foundation

View all ByrneWallace recent work